MR编号 | NO/H/0243/002 |
---|
药品名称 | Ceftazidime MIP 2 g |
---|
活性成分 | - Ceftazidime pentahydrate 1.0 g
|
---|
剂型 | Powder for solution for infusion/injection |
---|
上市许可持有人 | MIP Pharma GmbH
Kirkeler Strasse 41
D-66440 Blieskastel
Germany |
---|
参考成员国 - 产品名称 | Norway (NO) Ceftazidim MIP |
---|
互认成员国 - 产品名称 | - Germany (DE)
Ceftadizim MIP 2 g Pulver zur Herstellung einer Injektions- bzw. Infusionslösung - Denmark (DK)
- Netherlands (NL)
Ceftazidim MIP 2 g, poeder voor oplossing voor injectie of infusie - United Kingdom (Northern Ireland) (XI)
- Austria (AT)
Ceftazidim-MIP 2 g Pulver zur Herstellung einer Injektions-/Infusionslösung - France (FR)
- Spain (ES)
- Finland (FI)
- Poland (PL)
- Latvia (LV)
Ceftazidime MIP 2 g pulveris injekciju/infūziju šķīduma pagatavošanai - Lithuania (LT)
Ceftazidime MIP 2 g milteliai injekciniam ar infuziniam tirpalui - Estonia (EE)
CEFTAZIDIME MIP 2G - Hungary (HU)
CEFTAZIDIM MIP 2 g por oldatos injekcióhoz vagy infúzióhoz - Bulgaria (BG)
Ceftazidime-MIP - Czechia (CZ)
Ceftazidim MIP 2 g - Romania (RO)
Ceftazidima MIP 2 g pulbere pentru soluţie injectabilă/perfuzabilă - Slovakia (SK)
Ceftazidim Mylan 2 g
|
---|
许可日期 | 2015/02/12 |
---|
最近更新日期 | 2025/02/05 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|